OpSens is now part of

Visit Opsens at EuroPCR 2019

to category

Learn more about the benefits of OptoWire® as a pressure guidewire to diagnose and treat with confidence at EuroPCR 2019 by attending Opsens’ complimentary Case-In-Point session or visit Opsens at the exhibition: Booth #64, level 2.

The OptoWire features a large nitinol core with excellent torque response and deliverability. With the OptoWire you can diagnose and treat your patients with confidence. Opsens second generation fiber optic pressure guidewire is designed to provide the lowest drift in the industry while reducing procedural costs with the ability to deliver the PCI over the same guidewire.

Leading experts in coronary physiology will demonstrate the clinical utility of coronary physiology assessments and the second generation fiber optic pressure guidewire in various clinical situations.

Educational Case-In-Point Sponsored Session “Precision Meets Simplicity – Complex PCI Guided by a 2nd Generation Fiber Optic Physiology Guidewire” Sponsored by Opsens Medical

Thursday, May 23, 2019
12h15 -13h15
Room 252A / Level 2
Palais Des Congrès de Paris


  • To learn along clinical cases how the new OptoWire physiology guidewire can make the difference compared to the current pressurewires
  • To discover how to use the OpSens technology in bifurcations, serial lesions and CAD and aortic stenoses
  • To participate to the debate on the limitations related to the patient and the technology used during the casesTeach tips and tricks for successful pressure measurement


Prof. Emanuele Barbato
Department of Advanced Biomedical Sciences, University Federico II, Naples, Italy

Prof. Olivier Muller
Interventional Cardiologist / Cardiologist, University Hospital, Lausanne, Lausanne, Switzerland

Dr. Benjamin Faurie
Interventional Cardiologist, Groupe Hospitalier Mutualiste of Grenoble, France

Prof. Philip MacCarthy
Professor of Interventional Cardiology, King’s College Hospital, London, United Kingdom

Dr. Enrique Gutiérrez-Ibanez
Interventional Cardiologist, Hospital General Universitario Gregorio Marañón, Madrid, Spain


  • 12:15 PM – Session objectives – O. Muller
  • 12:20 PM – Case 1: bifurcation – B. Faurie
  • 12:27 PM – Discussion and audience interaction
  • 12:37 PM- Case 2: serial lesions / diffuse disease – P. MacCarthy
  • 12:44 PM – Discussion and audience interaction
  • 12:54 PM – Case 3: coronary artery disease in TAVI – E. Gutierrez-Ibanes
  • 1:01 PM – Discussion and audience interaction
  • 1:11 PM – Session evaluation and key learnings – E. Barbato

Schedule of EuroPCR 2019 Coronary Physiology Late-Breaking Science and Abstracts


EuroPCR Scientific Session Highlights

Wednesday May 22, 2019

Moderated e-Posters:
More tests for coronary physiology: variations on the same theme 

Posters’ Lab

  • 10:30 – Discrepant FFR/iFR results associated with lower levels of haemoglobin – Findings from the FiGARO registry – S. Jerabek (pending confirmation)
  • 10:40 – Clinical outcome of lesions with discordant results among different invasive physiologic indices: resting distal coronary to aortic pressure ratio, resting full-cycle ratio, diastolic pressure-ratio, iFR, and fractional flo – K.H. Choi
  • 10:50 – The prognostic value of diastolic pressure ratio immediately after successful PCI in all-comer patients – K. Masdjedi
  • 11:00 – Performance of quantitative flow reserve against combined near-infrared spectroscopy and IVUS – M. Dobrolinska
  • 11:10 – Impact of the double product on relation between iFR and FFR – M. Junya
  • 11:20 – Prognostic impact of contrast FFR – A.M. Leone
  • 11:30 – Intracoronary nitroglycerin plus non-ionic contrast accurately predict FFR result – I. Noval-Morillas
  • 11:40 – Mechanisms provoking myocardial hyperaemia: does adenosine mediate saline-induced hyperaemia – I. Colaiori
  • 11:50 – Influence of sex on relationship between total anatomical and physiologic disease burden and their prognostic implications in patients with coronary artery disease – C.H. Kim

New approaches in the functional assessment of coronary stenosis

Room 353

  • 14:45 – Haemodynamic and clinical impact in adult patients with anomalous aortic origin of the coronary artery evaluated with quantitative flow reserve – J. Adjedj
  • 14:58 – The impact of 3D quantitative coronary angiography based vessel FFR on heart team decision making: a pilot reclassification study – M. Tomaniak
  • 15:11 – Validation of quantitative flow reserve and residual quantitative flow reserve to predict FFR post stenting from the Does Optical Coherence Tomography Optimize Results of Stenting study (DOCTORS) population – J. Adjedj
  • 15:24 – Clinical relevance of functional angiography for non-culprit stenosis in patients with AMI – K.H. Choi
  • 15:37 – Agreement between quantitative flow ratio and FFR in assessment of functional significance of intermediate coronary artery stenosis – G. Ziubryte
  • 15:50 – Diagnostic accuracy of a fast computational approach to derive FFR from coronary CT angiography – S. Tu
  • 16:03 – Extended validation of novel 3D quantitative coronary angiography based software to calculate vessel FFR: the FAST EXTEND study – J. Daemen

Thursday May 23, 2019

Mismatch between coronary anatomy and physiology

Room 353
  • 10:30 – Comparison between optical frequency domain imaging and IVUS in PCI guidance for biolimus A9 eluting stent implantation (MISTIC-1) – Y. Ozaki
  • 10:43 – Correlation between stent expansion criteria and post-PCI FFR: insights from the DOCTORS study – N. Amabile
  • 10:56 – The interplay between lesions’ morphology and the coronary artery stenosis in non-culprit non-ischaemic native coronary lesions of diabetic patients – Data from COMBINE (OCT-FFR) study – T. Roleder
  • 11:09 – Correlation of FFR values with frequency of vulnerable plaque features in non-significant lesions – Insights from the COMBINE study – B. Berta
  • 11:22 – FFR derived from microcatheters vs. standard pressure wires: a stenosis-level meta-analysis – H. Seligman
  • 11:35 – New trials in coronary imaging and physiology – T. Warisawa
  • 11:48 – Resting Pd/Pa and FFR discordance affects the diagnostic performance of quantitative flow ratio with FFR as reference standard: results from an individual patient data meta-analysis – J. Westra
Hot Line / Late-Breaking Trials
Theatre Bordeaux
  • 14:45 – The use of a FFR-CT revascularization planning-tool to guide coronary artery disease management in patients with multivessel disease – E. Van Belle
  • 14:56 – Redefining physiological patterns (diffuse versus focal) of epicardial disease by coronary pressure pullbacks – C. Collet
  • 15:07 – A randomized trial evaluating on-line 3D optical frequency domain imaging guided PCI vs. angiography guided in bifurcation lesions – Y. Onuma
  • 15:18 – Optical coherence guidance for distal left main stenting – Final results of the ROCK II study – B. Cortese
  • 15:29 – A serial optical frequency domain imaging study of early and late vascular responses of sirolimus-eluting stent with bioresorbable polymer for treatment of STEMI and stable angina pectoris patients – Final results of MECHANISM-ULTIMASTER – Y. Morino
  • 15:40 – Accuracy of OCT-based FFR in identifying hemodynamic significance of coronary stenosis  – S. Tu
  • 15:51 – Prognostic value of quantitative flow ratio measured immediately after successful stent implantation: the international multicenter prospective HAWKEYE study – S. Biscaglia
  • 16:02 – Routine FFR measurement after PCI: two-year follow-up of the the FFR-search study – R. Diletti
CV Pipeline:
Innovations in imaging and physiology

Room 2 / Level 1
  • 16:30 – Stress aortic valve index with dobutamine for low-gradient aortic stenosis – J. Zelis
  • 16:43 – Coronary blood flow quantification from X-ray angiography – S. Vijayan
  • 16:56 – Stepwise cardiac CT manipulation to mimic transesophageal echocardiography – K.C. Huang
  • 17:09 – Digital variance angiography as a risk-reduction measure in peripheral endovascular intervention – V. Orias
  • 17:22 – TrackCath EVAR – Z. Rancic (pending confirmation)
  • 17:35 – Electronic high-resolution angioscope – O. Keita
  • 17:48 – Photoacoustic imaging of lipids in coronary atherosclerosis – lightning and thunder on a catheter – G. Van Soest
Moderated e-posters:
How imaging can help in daily practice

Posters’ Lab
  • 16:30 – Consecutive intravascular imaging assessment up to three years following implantation of resorbable magnesium scaffolds – H. Rai
  • 16:40 – Impact of coronary lesion geometry on plaque vulnerability – A CT study in patients with obstructive coronary artery disease and vulnerable atheromatous plaques – T. Benedek
  • 16:50 – Diagnostic accuracy of 320-detector CT for characterizing coronary atherosclerotic plaques: comparison with intravascular OCT – LF. Ybarra
  • 17:00 – Stent strut condition after imaging-guided vs. angiographic-guided emergency PCI with DES in ACS patients: OCT study – T. Nakamura
  • 17:10 – Coronary plaque rupture in stable coronary artery disease and ACS: an OCT study – L. Mariani
  • 17:20 – Predictors of suboptimal post-PCI FFR from pre-PCI OCT characteristics – A.J. Samdani
  • 17:30 – Angiography-derived functional assessment of left main coronary stenoses – S. . Goto (pending confirmation
  • 17:40 – The impact of plaque characteristics on volumetric stent expansion assessed by OCT – D. Jia
  • 17:50 – The influence of lipid plasma levels on maximal lipid core burden index assessed by near infrared spectroscopy – M. Dobrolinska

Link to EuroPCR website…